Dr. Valantine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
St. George's Hospital Medical SchoolClass of 1978
Certifications & Licensure
CA State Medical License 1988 - 2026
Clinical Trials
- IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Start of enrollment: 2005 Jan 01
- Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation Start of enrollment: 2010 Jul 01
- Heartsbreath Test for Heart Transplant Rejection Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 75 citationsSerial measurement of integrated ultrasonic backscatter in human cardiac allografts for the recognition of acute rejection.Tohru Masuyama, Hannah A. Valantine, R Gibbons, Ingela Schnittger, Richard L. Popp
Circulation. 1990-03-01 - 85 citationsFrequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakersAria DiBiase, Tak-Ming Tse, Ingela Schnittger, Lewis Wexler, Edward B. Stinson
The American Journal of Cardiology. 1991-06-15 - 264 citationsUniversal noninvasive detection of solid organ transplant rejectionThomas M. Snyder, Kiran K. Khush, Hannah A. Valantine, Stephen R. Quake
Proceedings of the National Academy of Sciences of the United States of America. 2011-04-12
Journal Articles
- Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart TransplantationKiran Khush, Alan C Yeung, Hannah Valantine, William F Fearon, Journal of Cardiac Failure
Other
- Induction and maintenance of immunosuppressive therapy in cardiac transplantationValantine HA, Pham MX
http://www.uptodate.com/contents/induction-and-maintenance-of-immunosuppressive-therapy-in-cardiac-t
UpToDate, Wolters Kluwer Health - 2012-04-06
Authored Content
- Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart TransplantationDecember 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Join now to see all
Press Mentions
Stanford Researchers Testing Ways to Improve Clinical Trial DiversityJune 22nd, 2022- CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement AwardApril 28th, 2022
- ISHLT Honors Hannah Valantine for Lifetime Achievement in Treating Advanced Heart DiseaseApril 28th, 2022
- Join now to see all
Grant Support
- Eradicating Stereotype Threat: Intervening To Retain And Advance Women FacultyNational Institute Of General Medical Sciences2010
- Genome Transplant Dynamics: Non-Invasive Sequencing-Based Diagnosis Of RejectionNational Institute Of Allergy And Infectious Diseases2010
- Transplant Arteriosclerosis: Viral And Host MechanismsNational Center For Research Resources2004–2007
- Host-Viral Immune Responses--Transplant ArteriosclerosisNational Institute Of Allergy And Infectious Diseases2001–2002
- Core--Clinical Research FacilityNational Institute Of Allergy And Infectious Diseases2001–2002
- Optimization Of Rodent Models Of Transplant CADNational Heart, Lung, And Blood Institute1999
- Immune Mediators Of Acute Cardiac Allograft DysfunctionNational Heart, Lung, And Blood Institute1991–1995
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
